Get the latest Science News and Discoveries
Promising personalized approach to liver cancer therapy made possible by DNA-based neoantigen research designed ... - EurekAlert
Results of a new clinical trial published in Nature Medicine show that a novel, personalized neoantigen vaccine therapy demonstrated promising anti-tumor efficacy in patients with liver cancer who failed their original front-line treatment. The foundational biomedical research leading to this important study and important outcome originated from research in the Vaccine & Immunotherapy Center at The Wistar Institute.
None
Or read this on Eureka Alert